Literature DB >> 7910017

Botulinum neurotoxin type G proteolyses the Ala81-Ala82 bond of rat synaptobrevin 2.

S Yamasaki1, T Binz, T Hayashi, E Szabo, N Yamasaki, M Eklund, R Jahn, H Niemann.   

Abstract

Tetanus toxin and the botulinum neurotoxins types A to F inhibit neurotransmitter release from presynaptic nerve endings by selectively proteolysing the synaptic proteins synaptobrevin, syntaxin, or SNAP-25. Here, we show that botulinum toxin type G cleaves rat synaptobrevin 2 between Ala81 and Ala82, a peptide bond that differs from those attacked by tetanus toxin and the botulinal toxins types B, D, and F. Synaptobrevin isoforms carrying a Gly in the P1 position are poor substrates. Analyses of N-terminal deletion mutants of rat synaptobrevin 2 showed that a substrate starting at Leu54 is cleaved efficiently, whereas substrates beginning at Leu60 or Phe77 are cleaved partially or not at all, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910017     DOI: 10.1006/bbrc.1994.1526

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Crystal structure of Clostridium botulinum neurotoxin protease in a product-bound state: Evidence for noncanonical zinc protease activity.

Authors:  Brent Segelke; Mark Knapp; Saloumeh Kadkhodayan; Rod Balhorn; Bernhard Rupp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-23       Impact factor: 11.205

2.  Mass Spectrometric Identification and Differentiation of Botulinum Neurotoxins through Toxin Proteomics.

Authors:  Suzanne R Kalb; John R Barr
Journal:  Rev Anal Chem       Date:  2013-08       Impact factor: 3.067

3.  Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.

Authors:  Joseph W Arndt; Wayne Yu; Fay Bi; Raymond C Stevens
Journal:  Biochemistry       Date:  2005-07-19       Impact factor: 3.162

4.  Lycopodium clavatum exine microcapsules enable safe oral delivery of 3,4-diaminopyridine for treatment of botulinum neurotoxin A intoxication.

Authors:  T L Harris; C J Wenthur; A Diego-Taboada; G Mackenzie; T S Corbitt; K D Janda
Journal:  Chem Commun (Camb)       Date:  2016-03-18       Impact factor: 6.222

5.  Epitope regions in the heavy chain of Clostridium botulinum type E neurotoxin recognized by monoclonal antibodies.

Authors:  T Kubota; T Watanabe; N Yokosawa; K Tsuzuki; T Indoh; K Moriishi; K Sanda; Y Maki; K Inoue; N Fujii
Journal:  Appl Environ Microbiol       Date:  1997-04       Impact factor: 4.792

6.  Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.

Authors:  Abby R Kroken; Faith C Blum; Madison Zuverink; Joseph T Barbieri
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

7.  Selective cleavage of SNAREs in sensory neurons unveils protein complexes mediating peptide exocytosis triggered by different stimuli.

Authors:  Jianghui Meng; J Oliver Dolly; Jiafu Wang
Journal:  Mol Neurobiol       Date:  2014-03-08       Impact factor: 5.590

8.  Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5.

Authors:  Suzanne R Kalb; Jakub Baudys; Theresa J Smith; Leonard A Smith; John R Barr
Journal:  Anal Chem       Date:  2014-03-13       Impact factor: 6.986

9.  Proposed BoNT/A and /B Peptide Substrates Cannot Detect Multiple Subtypes in the Endopep-MS Assay.

Authors:  Suzanne R Kalb; Jakub Baudys; Kaitlyn Kiernan; Dongxia Wang; François Becher; John R Barr
Journal:  J Anal Toxicol       Date:  2020-03-07       Impact factor: 3.367

10.  Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.

Authors:  Saedeh Dadgar; Zack Ramjan; Wely B Floriano
Journal:  J Med Chem       Date:  2013-03-29       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.